By the same token, low COX-2 protein expression leading to low levels of 15-D-PGJ2 may lead to less PPARγ expression or activation, fuelling inflammation and carcinogenesis, as noted in IBD and CRC. This evidence concerns the gene PPARG and inflammatory bowel disease.